Trial Identifier: | D8220C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03198650 |
Start Date: | June 2017 |
Primary Completion Date: | December 2024 |
Study Completion Date: | December 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan | Chiba-shi, Japan, 260-8717 |
Japan | Chuo-ku, Japan, 104-0045 |
Japan | Fukuoka-shi, Japan, 812-8582 |
Japan | Isehara-shi, Japan, 259-1193 |
Japan | Izumo-shi, Japan, 693-8501 |
Japan | Matsuyama-shi, Japan, 791-0280 |
Japan | Nagoya-shi, Japan, 464-8681 |
Japan | Nagoya-shi, Japan, 460-0001 |
Japan | Niigata-shi, Japan, 951-8520 |
Japan | Okayama-shi, Japan, 700-8558 |
Japan | Sapporo-shi, Japan, 060-8638 |
Japan | Sendai-shi, Japan, 980-8574 |
Japan | Shimotsuke-shi, Japan, 329-0498 |
Japan | Suita-shi, Japan, 565-0871 |